Continued misuse of orphan drug legislation: a life-threatening risk for mexiletine.

More search options...

Postema, PG; Schwartz, PJ; Arbelo, E; Bannenberg, WJ; Behr, ER; Belhassen, B; Brugada, J; Brugada, P; John Camm, A; Casado-Arroyo, R; et al. Postema, PG; Schwartz, PJ; Arbelo, E; Bannenberg, WJ; Behr, ER; Belhassen, B; Brugada, J; Brugada, P; John Camm, A; Casado-Arroyo, R; 't Hoen, E; Hollak, CEM; Kääb, S; Lambiase, PD; Leenhardt, A; Priori, SG; Probst, V; Stunnenberg, BC; Tfelt-Hansen, J; Van Engelen, BGM; Veltmann, C; Viskin, S; Wilde, AAM (2020) Continued misuse of orphan drug legislation: a life-threatening risk for mexiletine. Eur Heart J, 41 (5). pp. 614-617. ISSN 1522-9645 https://doi.org/10.1093/eurheartj/ehaa041
SGUL Authors: Behr, Elijah Raphael

Preview

PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].
Download (574kB) | Preview

Item Type:

Article

Additional Information:

This is a pre-copyedited, author-produced version of an article accepted for publication in European Heart Journal following peer review. The version of record Pieter G Postema, Peter J Schwartz, Elena Arbelo, Wilbert J Bannenberg, Elijah R Behr, Bernard Belhassen, Josep Brugada, Pedro Brugada, A John Camm, Ruben Casado-Arroyo, Ellen ‘t Hoen, Carla E M Hollak, Stefan Kääb, Pier D Lambiase, Antoine Leenhardt, Silvia G Priori, Vincent Probst, Bas C Stunnenberg, Jacob Tfelt-Hansen, Baziel G M Van Engelen, Christian Veltmann, Sami Viskin, Arthur A M Wilde, Continued misuse of orphan drug legislation: a life-threatening risk for mexiletine, European Heart Journal, Volume 41, Issue 5, 1 February 2020, Pages 614–617 is available online at: https://doi.org/10.1093/eurheartj/ehaa041

Keywords:

1102 Cardiorespiratory Medicine and Haematology, Cardiovascular System & Hematology

SGUL Research Institute / Research Centre:

Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)

Journal or Publication Title:

Eur Heart J

ISSN:

1522-9645

Language:

eng

Dates: